3.5.1.24: choloylglycine hydrolase
This is an abbreviated version!
For detailed information about choloylglycine hydrolase, go to the full flat file.
Word Map on EC 3.5.1.24
-
3.5.1.24
-
lactobacillus
-
cholesterol
-
deconjugation
-
plantarum
-
microbiota
-
cholesterol-lowering
-
bifidobacterium
-
taurodeoxycholic
-
cholic
-
taurocholic
-
glycocholic
-
drug development
-
glycodeoxycholic
-
farnesoid
-
co-aggregation
-
pentosaceus
-
rhamnosus
-
glycine-conjugated
-
pentosus
-
pediococcus
-
acylase
-
fermentum
-
auto-aggregation
-
taurine-conjugated
-
rogosa
-
medicine
-
food industry
-
taurochenodeoxycholic
-
oxgall
-
nutrition
- 3.5.1.24
- lactobacillus
- cholesterol
-
deconjugation
- plantarum
- microbiota
-
cholesterol-lowering
- bifidobacterium
-
taurodeoxycholic
-
cholic
-
taurocholic
-
glycocholic
- drug development
-
glycodeoxycholic
-
farnesoid
-
co-aggregation
- pentosaceus
- rhamnosus
-
glycine-conjugated
- pentosus
- pediococcus
- acylase
- fermentum
-
auto-aggregation
-
taurine-conjugated
-
rogosa
- medicine
- food industry
- taurochenodeoxycholic
-
oxgall
- nutrition
Reaction
Synonyms
BAH1, BFS26_06805, bile acid hydrolase, bile salt hydrolase, Bile-Salt-Hydrolase, BSH, BSH A, BSH B, BSH C, BSH1, BSH12, BSH2, BSH3, BSH4, BSH47, BSH56, BSHA, BSHB, BSHC, BT2086, C3745_01535, CBAH, CBH, CBSHalpha, CBSHbeta, CGH, cholylglycine hydrolase, Conjugated bile acid hydrolase, conjugated bile salt hydrolase, conjugated bile salt hydrolase alpha peptide, conjugated bile salt hydrolase beta, EFBG_01849, EfBSH, glycocholase, LaciP, LgBSH, linear amide C-N hydrolase, LJ1412, LJ_0056, LJ_1147, LsalN1, lsBSH, More, probiotic bile salt hydrolase, salt hydrolase
ECTree
Advanced search results
Application
Application on EC 3.5.1.24 - choloylglycine hydrolase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
food industry
medicine
nutrition
the broad substrate specificity nature of Lactobacillus salivarius enzyme may make it an ideal candidate for screening desired BSH inhibitors targeting various BSH enzymes
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
-
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
the enzyme is a target for BSH inhibitor development, overview
drug development
Lactiplantibacillus plantarum NCIMB 8826
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Lactiplantibacillus plantarum ATCC BAA-793
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Bifidobacterium longum subsp. suis LMG 21814
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Bifidobacterium animalis KL612
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Ligilactobacillus salivarius CGMCC 8198
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Ligilactobacillus salivarius NRRL B-30514
-
the broad substrate specificity nature of Lactobacillus salivarius enzyme may make it an ideal candidate for screening desired BSH inhibitors targeting various BSH enzymes
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Ligilactobacillus salivarius JCM1046
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Bifidobacterium bifidum ATCC 11863
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Ligilactobacillus salivarius LGM14476
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Limosilactobacillus reuteri CRL 1098
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Enterococcus faecalis NCIM 2403
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
Limosilactobacillus fermentum NCDO394
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
drug development
-
the enzyme is a target for BSH inhibitor development, overview
-
enzyme inhibitors are promising feed additives to replace antibiotic growth promoters for enhancing the productivity and sustainability of food animals
food industry
inhibitors are a promising alternatives to antibiotic growth promoters for enhanced animal growth performance and food safety, required since antibiotic growth promoter usage is linked to the emergence of antibiotic resistant bacteria. Enzyme BSH inhibitors are promising feed additives to replace antibiotic growth promoters for enhanced host lipid metabolism and growth performance
food industry
inhibitors are a promising alternatives to antibiotic growth promoters for enhanced animal growth performance and food safety, required since antibiotic growth promoter usage is linked to the emergence of antibiotic resistant bacteria. Enzyme BSH inhibitors are promising feed additives to replace antibiotic growth promoters for enhanced host lipid metabolism and growth performance
food industry
Ligilactobacillus salivarius NRRL B-30514
-
enzyme inhibitors are promising feed additives to replace antibiotic growth promoters for enhancing the productivity and sustainability of food animals
-
food industry
Ligilactobacillus salivarius NRRL B-30514
-
inhibitors are a promising alternatives to antibiotic growth promoters for enhanced animal growth performance and food safety, required since antibiotic growth promoter usage is linked to the emergence of antibiotic resistant bacteria. Enzyme BSH inhibitors are promising feed additives to replace antibiotic growth promoters for enhanced host lipid metabolism and growth performance
-
food industry
-
inhibitors are a promising alternatives to antibiotic growth promoters for enhanced animal growth performance and food safety, required since antibiotic growth promoter usage is linked to the emergence of antibiotic resistant bacteria. Enzyme BSH inhibitors are promising feed additives to replace antibiotic growth promoters for enhanced host lipid metabolism and growth performance
-
-
cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity
medicine
-
protein encapsulation is an excellent tool to protect enzymes during transit through gastric conditions and release enzyme activity in the proximal small intestine
medicine
protein encapsulation is an excellent tool to protect enzymes during transit through gastric conditions and release enzyme activity in the proximal small intestine
medicine
-
using bile salt deconjugation to lower serum cholesterol levels in hypercholesteremic patients and prevent hypercholesteremia in normal people is of great interest
medicine
-
effect of oral administration to Wistar rats of the immobilized bile salt hydrolase enzyme on serum cholesterol, triglyceride, high density lipoprotein levels and its application in the therapeutic treatment of hypercholesteremia, overview
medicine
active BSH derived from the probiotic Lactobacillus johnsonii strain La1 may yield anti-giardial effects in vitro and in vivo. The enzyme may be useful in approaches for the treatment of widely spread but neglected infectious disease, such as giardiasis, both in human and in veterinary medicine
medicine
bile salt hydrolase (BSH) active probiotic strains are being used in the treatment of hypercholesterolemia related diseases
medicine
-
active BSH derived from the probiotic Lactobacillus johnsonii strain La1 may yield anti-giardial effects in vitro and in vivo. The enzyme may be useful in approaches for the treatment of widely spread but neglected infectious disease, such as giardiasis, both in human and in veterinary medicine
-
medicine
-
bile salt hydrolase (BSH) active probiotic strains are being used in the treatment of hypercholesterolemia related diseases
-
BSH is a key mechanistic microbiome target for the development of non-antibiotic food additives to improve animal feed production and for the design of measures to control obesity in humans
nutrition
Ligilactobacillus salivarius NRRL B-30514
-
BSH is a key mechanistic microbiome target for the development of non-antibiotic food additives to improve animal feed production and for the design of measures to control obesity in humans
-